Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Postoperative pain and influencing factors after prophylactic extraction of impacted mandibular third molars: a multicenter prospective cohort study.

BMC oral health·2025

Same author

Recovery of valuable elements from coal fly ash: A review.

Environmental research·2025

Same author

Nontargeted Analysis Reveals Organofluorine Pharmaceutical Compounds Responsible for Formation of Toxic Disinfection Byproducts in a Drinking Water Treatment Plant in China.

Environmental science & technology·2025

Same author

Ultrasound-based deep learning to differentiate salivary gland tumors.

Oral surgery, oral medicine, oral pathology and oral radiology·2025

Same author

Single-cell MultiOmics and spatial transcriptomics demonstrate neuroblastoma developmental plasticity.

Developmental cell·2025

Same author

Mapping Tracking Control to Cascading Optimization in Discrete Strict-Feedback Systems: A Hierarchical Learning Approach.

IEEE transactions on neural networks and learning systems·2025

Search research articles

Related Experiment Video

Updated: Apr 21, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Cell-based therapy for therapeutic lymphangiogenesis.

Shuqun Qi¹, Jian Pan

¹1 State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University , Chengdu, China .

Stem Cells and Development

|October 21, 2014

Summary

This summary is machine-generated.

Mesenchymal stem cells (MSCs) show promise for treating lymphedema, a condition with limited options. This review explores MSCs and other cell therapies for lymphatic regeneration, discussing their clinical potential.

More Related Videos

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Experiment Videos

Last Updated: Apr 21, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Area of Science:

Regenerative Medicine
Cell Therapy
Lymphatic Disorders

Background:

Lymphedema is a chronic condition with currently ineffective treatments.
Stem cell therapies offer potential new treatment avenues for lymphatic disorders.
Mesenchymal stem cells (MSCs) are a leading candidate due to accessibility and fewer ethical concerns.

Purpose of the Study:

To review cell-based therapies for lymphedema.
To highlight the role of MSCs in lymphatic regeneration.
To discuss the clinical strengths, weaknesses, and future of MSCs for lymphedema.

Main Methods:

Literature review of basic research, preclinical studies, and clinical trials.
Focus on mesenchymal stem cells (MSCs) and their therapeutic potential.
Analysis of clinical applications and future perspectives.

Main Results:

Various cell therapies are being investigated for lymphedema.
MSCs demonstrate significant promise for lymphatic regeneration.
Strengths and weaknesses of current cell-based approaches are identified.

Conclusions:

Mesenchymal stem cells (MSCs) represent a promising therapeutic strategy for lymphedema.
Further research and clinical trials are needed to optimize MSC-based treatments.
Cell therapy holds potential for advancing lymphedema management.